Keep up to date with the latest developments!
21 September 2022
CytoReason aims for $110 million in net income through partnership with Pfizer

On Sept. 20, the companies announced a renewed partnership with a $20 million investment from Pfizer, projected to total $110 […]

21 June 2022
Finlife Venture Partners Inc. has announced the release of an analytics platform.

In today’s world, information is the most expensive resource, and its quality and speed of receipt is an important tool […]

Perfect timing invest - always.
The sooner you start investing, the better
Difficult times call for new solutions

    How long to wait? Dial now: +420 234 092 102
    Or add to social networks: